Waist of time and moneyI wonder why it took them 2 years and millions of dollars to finally realizing the only assets they have are the legacy drugs. Personnally, I was vocal against their oncology program because of their constant lying. They said they have seen in one cancer a tumor shrink by 58% meaning there is efficacy. If this is the case why saying in their last communication they are making pause because efficacy is not worth it.
I hope this gate approach is not a new way of spending money in programs that go nowhere. They should make the company profitable, generate enough cash then find a partner to take over. Paul Levesque and this board are definitely unfit for the job.